Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Reimbursement

    MS-DRG(MS-DRG)

    In one line
    Medicare's inpatient hospital payment classification system.
    Definition
    Medicare Severity Diagnosis-Related Groups classify inpatient stays into payment groups based on diagnosis, procedures, age, and complications. Each MS-DRG carries a relative weight; the hospital is paid a bundled rate regardless of actual cost. CMS updates MS-DRG definitions and relative weights each year through the IPPS rule, using cost reports and claims data. Groups often have tiers for no complications, complications (CC) and major complications (MCC). If a new device is costly and the DRG payment does not reflect it, manufacturers may request a DRG reassignment or an NTAP.
    Why it matters
    For inpatient device-based procedures, MS-DRG assignment determines whether the hospital is paid enough to cover the device cost. Inadequate MS-DRG mapping is a major commercial barrier; NTAP and new technology reassignment are remedies.
    Common pitfalls
    • •Hospitals may inadvertently undercode or overcode, leading to incorrect reimbursement and potential audit scrutiny.
    • •Device manufacturers might misunderstand how device costs are incorporated into MS-DRG payments, impacting market access strategies.
    • •A lack of proper documentation for a device or procedure can lead to an unfavorable MS-DRG assignment.
    • •Assuming that an innovative MedTech product will automatically receive adequate reimbursement without specific CMS pathways like NTAP is a common mistake.
    • •Failing to consider the impact of MS-DRG assignment on post-market surveillance costs or potential recalls can lead to financial strain.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.